Improving Treatment Outcomes for Juvenile Arthritis with Xeljanz

A 7-year-old’s symptoms persisted despite therapy. Our pharmacist worked with the physician to evaluate options and implement a clinically appropriate change—speeding relief and eliminating unnecessary medication spend.